360 NEWS360 NEWS

Business · National

Natco Pharma gets USFDA’s EIR for Visakhapatnam plant

August inspection drew four Form-483 observations; regulator classifies as Voluntary Action Indicated

Verified Timeline

No verified timeline updates.

Voluntary Reader Opinion

What is your view on “Natco Pharma gets USFDA’s EIR for Visakhapatnam plant”?

This is self-selected reader participation, not representative scientific polling.